---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-008301"
form_type: "8-K"
ticker: "SVRA"
cik: "0001160308"
company_name: "Savara Inc"
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:01:59.057935+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Savara updates corporate presentation; no material new disclosures

## Summary
- Corporate presentation posted on IR website and furnished as exhibit.
- Reaffirms focus on rare respiratory diseases; no new clinical or financial data.
- No changes to guidance, pipeline, or leadership disclosed.

## SEC filing metadata
- accession: 0001193125-26-008301
- form_type: 8-K
- ticker: SVRA
- cik: 0001160308
- company_name: Savara Inc
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160308/000119312526008301/0001193125-26-008301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160308/000119312526008301/d24211d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-008301
- JSON: https://secwatch.observer/filing/0001193125-26-008301.json
- Plain text: https://secwatch.observer/filing/0001193125-26-008301.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.